Biotech16 hours ago
Sotatercept: A Breakthrough Therapy for Pulmonary Arterial Hypertension in Spain
Pulmonary arterial hypertension (PAH) is a rare, disabling disease with complex diagnosis. MSD introduced sotatercept, Europe’s first activin signaling inhibitor for PAH, improving vascular balance and...